Biohaven Research Ltd. (CIK: 0001935979) EDGAR, Information, Filings... CompaniesBIO.Com

Biohaven Research Ltd.

Mailing address
215 CHURCH STREET, NEW HAVEN, Virgin Islands, British, 06510
Phone
203-404-0410
State location
Connecticut
State of incorporation
Virgin Islands, British
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Biohaven Research Ltd. (CIK: 0001935979) is an American company incorporated in the state of Connecticut. Head office is located at 215 CHURCH STREET, NEW HAVEN, Connecticut, 06510. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Biohaven Research Ltd. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Clark George C.	0001878290	Nov-08-2022	officer: VP, Chief Accounting Officer
CHILDS JOHN W	0001027035	Oct-03-2022	director
GREGORY JULIA P	0001226675	Oct-03-2022	director
HUGIN ROBERT J	0001232505	Oct-03-2022	director
Bailey Gregory	0001329505	Oct-03-2022	director
Heffernan Michael Thomas	0001448914	Oct-03-2022	director
Biohaven Pharmaceutical Holding Co Ltd.	0001689813	Oct-03-2022	10 percent owner
Gentile Kimberly	0001704186	Oct-03-2022	officer: SVP, Clinical Operations
Coric Vlad	0001704317	Oct-03-2022	director, officer: Chief Executive Officer
Mehta Kishan	0001850520	Oct-03-2022	director
Buten Matthew	0001898799	Oct-03-2022	officer: Chief Financial Officer
Antonijevic Irina	0001926476	Oct-03-2022	director
Car Bruce	0001798876	Sep-28-2022	officer: Chief Scientific Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Biohaven Research Ltd.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001628280-24-037576 (34 Act) Size: KB	Aug-16-2024	001-41477 241217182
424B7	Document	Prospectus filed pursuant to Rule 424(b)(7) Acc-no: 0001628280-24-037575 (33 Act) Size: KB	Aug-16-2024	333-274822 241217138
8-K	Document	Current report filing Acc-no: 0001628280-24-037568 (34 Act) Size: KB	Aug-16-2024	001-41477 241217018
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001628280-24-037565 (33 Act) Size: KB	Aug-16-2024	333-274822 241216986
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001935979-24-000069 (34 Act) Size: KB	Aug-09-2024	001-41477 241192752
8-K	Document	Current report filing Acc-no: 0001935979-24-000063 (34 Act) Size: KB	Aug-08-2024	001-41477 241188666
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-24-005805 ( Act) Size: 0 KB	Jul-19-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-24-005174 ( Act) Size: 0 KB	Jun-20-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-24-004529 ( Act) Size: 0 KB	May-31-2024
8-K	Document	Current report filing Acc-no: 0001935979-24-000053 (34 Act) Size: KB	May-17-2024	001-41477 24960577
424B7	Document	Prospectus filed pursuant to Rule 424(b)(7) Acc-no: 0001935979-24-000052 (33 Act) Size: KB	May-17-2024	333-274822 24960546
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-24-004045 ( Act) Size: 0 KB	May-15-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-24-004011 ( Act) Size: 0 KB	May-14-2024
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001935979-24-000048 (33 Act) Size: KB	May-09-2024	333-279258 24930923
8-K	Document	Current report filing Acc-no: 0001935979-24-000047 (34 Act) Size: KB	May-09-2024	001-41477 24930805
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001935979-24-000046 (34 Act) Size: KB	May-09-2024	001-41477 24930668
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-24-003755 ( Act) Size: 0 KB	May-02-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-24-003754 ( Act) Size: 0 KB	May-02-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-24-003753 ( Act) Size: 0 KB	May-02-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-24-003752 ( Act) Size: 0 KB	May-02-2024

Recent 20 filings. View all Biohaven Research Ltd. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Biohaven Research Ltd. overview
Biohaven Research Ltd. job
Biohaven Research Ltd. stock
Biohaven Research Ltd. ownership
Biohaven Research Ltd. CEO
Biohaven Research Ltd. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.